 |
|
URLC10 peptide/Montanide ISA51 vaccine
A cancer vaccine containing URLC10 (up-regulated lung cancer 10) epitopes with potential immunostimulatory and antineoplastic activities. Upon administration, URL peptide vaccine may stimulate a cytotoxic T lymphocyte (CTL) response against URLC10-expressing tumor cells. Up-regulated in lung and esophageal cancers, the function of URLC10 is unknown. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
|
|
